Antibody Therapeutics Patients First!

공지사항

Interview of Dr. Jin-San Yoo, CEO of PharmAbcine with informa
  • 글쓴이 관리자
  • 작성일 2018-09-03 16:46:00
  • 조회수 90
첨부파일 Interview,informa_180903.pdf

Interview of Dr. Jin-San Yoo, CEO of PharmAbcine with informa


"PharmAbcine's Hopes Rise As Tanibirumab Set For Keytruda Combo Trials"



PharmAbcine CEO Jin-San Yoo talks to Scrip about the company’s overseas clinical trial strategy, pipeline assets, and ambitions for lead candidate
TTAC-0001, which the company sees as superior to Avastin. The Korean biotech, which is engaged in various global collaborations on its investigative 
antibody drugs, hopes that tie-ups can lead to bigger outcomes going forward.

 Please check  PDF file for details.


목록





이전글 PharmAbcine, a clinical stage immuno-oncology company announced that PharmAbcine...
다음글 PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...